The characteristic presentation of RM involves nasal congestion without rhinorrhea, postnasal drip, or sneezing following several days of decongestant use. This condition typically occurs after 5–7 days of use of topical decongestants. Patients often try increasing both the dose and the frequency of nasal sprays upon the onset of RM, worsening the condition. The swelling of the nasal passages caused by rebound congestion may eventually result in permanent turbinate hypertrophy, which may block nasal breathing until surgically removed. Commercial introduction of oxymetazoline brand Afrin. The prolonged use of nasal vasoconstrictors causes<unk>
Rhinitis medicamentosa
Contact stomatitis
Lymphedema–distichiasis syndrome
Fusariosis
Acheiria
Streptococcal intertrigo
Visceral larva migrans
Honeymoon rhinitis